User profiles forDejan Radovanovic
 |
Dejan Radovanovic
Attending Physician, Pulmonary Unit, Luigi Sacco University Hospital, University of Milan …
Verified email at unimi.it
Cited by 1341 |
Prolonged low-dose methylprednisolone in patients with severe COVID-19 pneumonia
…, M Parati, M Villani,DRadovanovic… - Open forum …, 2020 - academic.oup.com
Background In hospitalized patients with coronavirus disease 2019 (COVID-19) pneumonia,
progression to acute respiratory failure requiring invasive mechanical ventilation (MV) is …
progression to acute respiratory failure requiring invasive mechanical ventilation (MV) is …
Helmet CPAP treatment in patients with COVID-19 pneumonia: a multicentre cohort study
S Aliberti,DRadovanovic, F Billi… - European …, 2020 - Eur Respiratory Soc
… Stefano Aliberti,Dejan
Radovanovic, Filippo Billi, Giovanni Sotgiu, Matteo Costanzo,
Tommaso Pilocane, Laura Saderi, Andrea Gramegna, Angelo Rovellini, Luca Perotto …
Tommaso Pilocane, Laura Saderi, Andrea Gramegna, Angelo Rovellini, Luca Perotto …
Helmet CPAP to treat acute hypoxemic respiratory failure in patients with COVID-19: a management strategy proposal
DRadovanovic, M Rizzi,S Pini, M Saad… - Journal of clinical …, 2020 - mdpi.com
Since the beginning of March 2020, the coronavirus disease 2019 (COVID-19) pandemic
has caused more than 13,000 deaths in Europe, almost 54% of which has occurred in Italy. …
has caused more than 13,000 deaths in Europe, almost 54% of which has occurred in Italy. …
Enhanced platelet inhibition treatment improves hypoxemia in patients with severe Covid-19 and hypercoagulability. A case control, proof of concept study
M Viecca,DRadovanovic,GB Forleo… - Pharmacological research, 2020 - Elsevier
Patients affected by severe coronavirus induced disease-2019 (Covid-19) often experience
hypoxemia due to alveolar involvement and endothelial dysfunction, which leads to the …
hypoxemia due to alveolar involvement and endothelial dysfunction, which leads to the …
[HTML][HTML]Severity of respiratory failure at admission and in-hospital mortality in patients with COVID-19: a prospective observational multicentre study
Objectives COVID-19 causes lung parenchymal and endothelial damage that lead to hypoxic
acute respiratory failure (hARF). The influence of hARF severity on patients’ outcomes is …
acute respiratory failure (hARF). The influence of hARF severity on patients’ outcomes is …
[HTML][HTML]How to manage COVID-19 vaccination in immune-mediated inflammatory diseases: An expert opinion by IMIDs Study Group
…,PS Morpurgo, M Nebuloni,DRadovanovic… - Frontiers in …, 2021 - frontiersin.org
Since March 2020, the outbreak of Sars-CoV-2 pandemic has changed medical practice and
daily routine around the world. Huge efforts from pharmacological industries have led to the …
daily routine around the world. Huge efforts from pharmacological industries have led to the …
Prevalence and etiology of community-acquired pneumonia in immunocompromised patients
…Dejan
Radovanovic,Dejan
Radovanovic… Marta Francesca Di Pasquale, Giovanni Sotgiu,
安德里亚·GramegnaDejan Radovanovic, Silvia Terraneo, Luis F Reyes, Jan Rupp, Juan …
安德里亚·GramegnaDejan Radovanovic, Silvia Terraneo, Luis F Reyes, Jan Rupp, Juan …
[HTML][HTML]A systematic review on tracheostomy decannulation: a proposal of a quantitative semiquantitative clinical score
…,A Gramegna,DRadovanovic… - BMC …, 2014 - bmcpulmmed.biomedcentral.com
Tracheostomy is one of the most common surgical procedures performed in critical care
patient management; more specifically, ventilation through tracheal cannula allows removal of …
patient management; more specifically, ventilation through tracheal cannula allows removal of …
Mortality and clinical outcomes in patients with COVID-19 pneumonia treated with non-invasive respiratory support: a rapid review
DRadovanovic年代科波拉E Franceschi…- - - - - -《关键…, 2021 - Elsevier
Introduction and aim Non-invasive ventilation (NIV) and continuous positive airway pressure
(CPAP) have been widely employed to treat acute respiratory failure secondary to COVID-…
(CPAP) have been widely employed to treat acute respiratory failure secondary to COVID-…
[HTML][HTML]Psoriasis and respiratory comorbidities: the added value of fraction of exhaled nitric oxide as a new method to detect, evaluate, and monitor psoriatic systemic …
P Santus, M Rizzi,DRadovanovic, A Airoldi… - BioMed research …, 2018 - hindawi.com
Psoriasis is a chronic inflammatory systemic disease characterized by a wide range of
comorbidities. Respiratory comorbidities are currently poorly characterized and with discordant …
comorbidities. Respiratory comorbidities are currently poorly characterized and with discordant …